PetIQ, Inc. (PETQ)
Market Cap | 530.27M |
Revenue (ttm) | 1.07B |
Net Income (ttm) | 12.78M |
Shares Out | 29.19M |
EPS (ttm) | 0.43 |
PE Ratio | 41.91 |
Forward PE | 21.20 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 228,665 |
Open | 18.04 |
Previous Close | 18.14 |
Day's Range | 17.98 - 18.74 |
52-Week Range | 8.75 - 22.98 |
Beta | 1.76 |
Analysts | Strong Buy |
Price Target | 29.33 (+62.76%) |
Earnings Date | Nov 7, 2023 |
About PETQ
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the ... [Read more]
Full Company ProfileFinancial Performance
In 2022, PetIQ's revenue was $921.51 million, a decrease of -1.18% compared to the previous year's $932.53 million. Losses were -$48.21 million, 201.9% more than in 2021.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for PETQ stock is "Strong Buy." The 12-month stock price forecast is $29.33, which is an increase of 62.76% from the latest price.
News

PetIQ, Inc. to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023
EAGLE, Idaho, Oct. 17, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results f...

PetIQ, Inc. Reports Second Quarter 2023 Financial Results
Record Second Quarter 2023 Net Sales Increase 25% to $314.5 Million Net Sales and Adjusted EBITDA Exceeds Company's Second Quarter 2023 Guidance Record Second Quarter Cash from Operations of $57.7 M...

PetIQ, Inc. to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
EAGLE, Idaho, July 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results f...

PetIQ, Inc. to Participate in Two Upcoming June Investor Conferences
EAGLE, Idaho, June 01, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced members of the management team wil...

PetIQ, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results ...

PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Mar...

PetIQ, Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results f...

Simple Mills Appoints Sheryl O'Loughlin to Board of Directors
CHICAGO--(BUSINESS WIRE)--Simple Mills, the company on a mission to advance the holistic health of the planet and its people through delicious, better-for-you foods, today announced the addition of ...

PetIQ, Inc. Reports Third Quarter 2022 Financial Results
Third Quarter 2022 Net Sales of Approximately $210 Million at the High-End of Guidance Adjusted EBITDA Exceeds Company's Third Quarter Guidance Reports Record Quarterly Cash from Operations of $64.5...

PetIQ, Inc. to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022
EAGLE, Idaho, Oct. 19, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results f...

PetIQ, Inc. to Present at the William Blair 42nd Annual Growth Stock Conference
EAGLE, Idaho, May 23, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that members of the management team...

PetIQ, Inc. Appoints Accomplished Retail Operations Executive, John Pearson, to Senior Vice President, Head of Services Division
EAGLE, Idaho, May 18, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of accomplished ret...

PetIQ, Inc. Announces Executive Leadership Team Changes
Susan Sholtis, President to Leave the Company, Michael Smith, Executive Vice President Products, to Become President and Chief Operating Officer Susan Sholtis, President to Leave the Company, Michael ...

PetIQ, Inc. to Report First Quarter 2022 Financial Results on Wednesday, May 4, 2022
EAGLE, Idaho, April 13, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results ...

PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2021 Financial Results
Reports Fourth Quarter Net Sales of $196.6 Million and Full Year Net Sales of $932.5 Million

PetIQ, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 1, 2022
EAGLE, Idaho, Feb. 08, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the fou...

PetIQ, Inc. Announces Appointment of Financial Executive Kenneth Walker to the Board of Directors
EAGLE, Idaho, Jan. 06, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of Kenneth Walker ...

PetIQ, Inc. Reports Record Third Quarter 2021 Financial Results
Reports Record Third Quarter Net Sales of $210.5 Million, an Increase of 29.9% Year-Over-Year Reports Record Third Quarter Net Sales of $210.5 Million, an Increase of 29.9% Year-Over-Year

PetIQ, Inc. to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021
EAGLE, Idaho, Oct. 20, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the thi...

PetIQ, Inc. to Present at the Jefferies Virtual Pet Care Summit
EAGLE, Idaho, Sept. 09, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that members of the management te...

Barron's Worst: Coinbase, PetIQ, and 3 More Stocks That Have Done Nothing But Drop
We're far from perfect with our stock picks, as these stinkers show, but we'll gladly admit when our calls go wrong.

PetIQ, Inc. to Report Second Quarter 2021 Financial Results on Wednesday, August 4, 2021
EAGLE, Idaho, July 22, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the sec...

PetIQ, Inc. to Participate in Two Upcoming Virtual Investor Conferences
EAGLE, Idaho, May 26, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced members of the management team will...

Growth Stock Spotlight: Acquisition Pits CSOC as Fresh Option in Booming Petcare Market
While the market has taken a beating over recent days, pullbacks are the mother's milk of effective investment strategies, and shrewd market participants will already have a growing shopping list on h...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PetIQ, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
NEW YORK, May 3, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cl...